Youdim MB - Search Results

1

Neurotoxicity and neuroprotection in Parkinson's disease.

Lange KW, Youdim MB, Riederer P. Lange KW, et al. Among authors: youdim mb. J Neural Transm Suppl. 1992;38:27-44. J Neural Transm Suppl. 1992. PMID: 1491247 Review.

2

Genomic aspects of sporadic Parkinson's disease.

Riederer P, Youdim MB, Mandel S, Gerlach M, Grünblatt E. Riederer P, et al. Among authors: youdim mb. Parkinsonism Relat Disord. 2008;14 Suppl 2:S88-91. doi: 10.1016/j.parkreldis.2008.04.009. Epub 2008 Jun 27. Parkinsonism Relat Disord. 2008. PMID: 18585078 Review.

3

Potential sources of increased iron in the substantia nigra of parkinsonian patients.

Gerlach M, Double KL, Youdim MB, Riederer P. Gerlach M, et al. Among authors: youdim mb. J Neural Transm Suppl. 2006;(70):133-42. doi: 10.1007/978-3-211-45295-0_21. J Neural Transm Suppl. 2006. PMID: 17017520 Review.

4

The relevance of iron in the pathogenesis of Parkinson's disease.

Sian-Hülsmann J, Mandel S, Youdim MB, Riederer P. Sian-Hülsmann J, et al. Among authors: youdim mb. J Neurochem. 2011 Sep;118(6):939-57. doi: 10.1111/j.1471-4159.2010.07132.x. Epub 2011 Jan 31. J Neurochem. 2011. PMID: 21138437 Free article. Review.

5

Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease.

Riederer P, Dirr A, Goetz M, Sofic E, Jellinger K, Youdim MB. Riederer P, et al. Among authors: youdim mb. Ann Neurol. 1992;32 Suppl:S101-4. doi: 10.1002/ana.410320717. Ann Neurol. 1992. PMID: 1510366 Review. No abstract available.

6

MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease.

Gerlach M, Riederer P, Przuntek H, Youdim MB. Gerlach M, et al. Among authors: youdim mb. Eur J Pharmacol. 1991 Dec 12;208(4):273-86. doi: 10.1016/0922-4106(91)90073-q. Eur J Pharmacol. 1991. PMID: 1815982 Review.

7

Brain iron and ferritin in Parkinson's and Alzheimer's diseases.

Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim MB. Jellinger K, et al. Among authors: youdim mb. J Neural Transm Park Dis Dement Sect. 1990;2(4):327-40. doi: 10.1007/BF02252926. J Neural Transm Park Dis Dement Sect. 1990. PMID: 2078310

8

The role of monoamine oxidase, iron-melanin interaction, and intracellular calcium in Parkinson's disease.

Youdim MB, Ben-Shachar D, Riederer P. Youdim MB, et al. J Neural Transm Suppl. 1990;32:239-48. doi: 10.1007/978-3-7091-9113-2_34. J Neural Transm Suppl. 1990. PMID: 2089094 Review.

9

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.

Sofic E, Riederer P, Heinsen H, Beckmann H, Reynolds GP, Hebenstreit G, Youdim MB. Sofic E, et al. Among authors: youdim mb. J Neural Transm. 1988;74(3):199-205. doi: 10.1007/BF01244786. J Neural Transm. 1988. PMID: 3210014

10

Selegiline: a molecule with innovative potential.

Tábi T, Vécsei L, Youdim MB, Riederer P, Szökő É. Tábi T, et al. Among authors: youdim mb. J Neural Transm (Vienna). 2020 May;127(5):831-842. doi: 10.1007/s00702-019-02082-0. Epub 2019 Sep 27. J Neural Transm (Vienna). 2020. PMID: 31562557 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

607 results

Search Page